Therapeutic Areas definition

Therapeutic Areas means the areas of hormone replacement and urologic disease, including urinary incontinence. “University License Agreement” is defined in the Recitals. 06/20/2003 ** CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.
Sample 1Sample 2
Therapeutic Areas means the areas of oral mucosal delivery for prevention and treatment of all forms of pain including acute and chronic pain for both human and veterinary use.
Sample 1Sample 2
Therapeutic Areas means (1) diabetes, (2) pre-diabetes, (3) obesity, (4) behavioral health, (5) musculoskeletal conditions only when bundled with diabetes, pre-diabetes, obesity and/or behavioral health, (6) hypertension only when bundled with only when bundled with diabetes, pre-diabetes, obesity or behavioral health, (7) any therapeutic area other than the foregoing (1) through (6) which Dario independently, commercializes and integrates into the Solution, and (8) any therapeutic area other than the foregoing (1) through (6) that is integrated by Dario into the Solution pursuant to Dario’s acquisition of a Third Party’s business or assets in such therapeutic area.
Sample 1

Examples of Therapeutic Areas in a sentence

  • In the event Developments or Licensee Patents may assist Licensor with respect to Licensor’s development of products involving Licensor Technology and Licensor Know-How outside the Therapeutic Areas, Licensee will grant Licensor a non-exclusive license to such Developments and/or Licensee Patents for use outside the Therapeutic Areas on terms to be negotiated in good faith by the Parties.

  • Licensee will be responsible for obtaining, at its cost and expense, all Regulatory Approvals required for marketing and sale of Products in the Therapeutic Areas in the Territory.

  • To the extent that 3DP or an Affiliate Controls any Non-uPA Inhibitor Compounds, 3DP agrees to negotiate in good faith with Schering to grant an exclusive, worldwide, sublicensable license to Schering to pursue development and commercialization of such Non-uPA Inhibitor Compounds in one or more Separate Therapeutic Areas in the Field.

  • The Joint Research Committee shall have the day-to-day management responsibilities for the Target Validation Program and the Antisense Drug Discovery Program in the Collaboration Therapeutic Areas.

  • An additional purpose of the Target Validation Program is to validate and prioritize Targets related to the Collaboration Therapeutic Areas for potential inclusion in the Antisense Drug Discovery Program.

  • If Schering, having Accepted a Lead Candidate, Back-Up or Follow- Up decides, at any stage, to terminate pharmaceutical development of such Lead Candidate, Back-Up or Follow-Up, Schering agrees to negotiate in good faith with 3DP at such time to provide a release of rights to 3DP to pursue development of such Licensed Compound(s) in Separate Therapeutic Areas designated by 3DP and which Schering confirms are not of interest to Schering.

  • Additional Know-How shall be made available to Licensee promptly after it becomes known by Licensor that it is or may be applicable to the Product in the Therapeutic Areas.

  • The goal of the drug discovery Target Validation Program is to provide information regarding gene functionalization and validation for drug discovery with respect to Targets related to the Collaboration Therapeutic Areas.

  • The goal of the Antisense Drug Discovery Program is to develop Drug Discovery ASO Compounds directed against Targets related to the Collaboration Therapeutic Areas and to qualify such Drug Discovery ASO Compounds as Development Candidates for development by Lilly or by Isis as pharmaceutical products.

  • In the event that Licensor has a bona fide offer from a third-party, as reflected in a term sheet, letter of intent or similar document signed by Licensor and the third-party, for a License of Licensor Patents and/or Licensor Know-How in connection with areas not included in the Therapeutic Areas (“Bona-fide Term Sheet”), Licensor shall deliver the Bona-fide Terra Sheet to Licensee; provided, however, Licensee shall keep such Bona-fide Term Sheet confidential, not to disclose it to any third-party,.


More Definitions of Therapeutic Areas

Therapeutic Areas means (1) diabetes, (2) pre-diabetes, (3) obesity, (4) behavioral health, (5) musculoskeletal conditions only when bundled with diabetes, pre-diabetes, obesity and/or behavioral health, (6) hypertension only when bundled with only when bundled with diabetes, pre-diabetes, obesity or behavioral health, (7) any therapeutic area other than the foregoing (1) through (6) which Xxxxx independently, commercializes and integrates into the Solution, and (8) any therapeutic area other than the foregoing (1) through (6) that is integrated by Xxxxx into the Solution pursuant to Xxxxx’s acquisition of a Third Party’s business or assets in such therapeutic area.
Sample 1
Therapeutic Areas means the areas of oral mucosal delivery for hormone replacement and urologic disease, including urinary incontinence.”
Sample 1

Related to Therapeutic Areas

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Licensed Area means the area in which the Licensee is authorised to

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Biological Material means any material containing genetic information and capable of reproducing itself or being reproduced in a biological system;

  • Competing Products means any product or service in existence or under development that competes with any product or service of the Company Group about which the Participant obtained Confidential Information or for which the Participant provided advisory services or had sales, origination, marketing, production, distribution, research or development responsibilities in the last twenty-four (24) months of employment with the Company Group.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Licensed Field means all fields of use.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Competing Product means [***].

  • Biological Materials means certain tangible biological materials that are necessary for the effective exercise of the Patent Rights, which materials are described on Exhibit A, as well as tangible materials that are routinely produced through use of the original materials, including, for example, any progeny derived from a cell line, monoclonal antibodies produced by hybridoma cells, DNA or RNA replicated from isolated DNA or RNA, recombinant proteins produced through use of isolated DNA or RNA, and substances routinely purified from a source material included in the original materials (such as recombinant proteins isolated from a cell extract or supernatant by non-proprietary affinity purification methods). These Biological Materials shall be listed on Exhibit A, which will be periodically amended to include any additional Biological Materials that Medical School may furnish to Company.

  • sensitive area means any of the following—

  • Active Pharmaceutical Ingredient or “API” means the active pharmaceutical substance of the Drug in bulk form prior to incorporation into the Product.

  • animals means animals as defined in the Terrestrial Animal Health Code or the Aquatic Animal Health Code of the World Organisation for Animal Health (OIE), respectively;

  • Service Areas means those areas within the Building used for stairs, elevator shafts, flues, vents, stacks, pipe shafts and other vertical penetrations (but shall not include any such areas for the exclusive use of a particular tenant).